Fox Chase Cancer Center’s Camille Ragin Awarded AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship

Dr. Ragin AACR
Camille Ragin, PhD, MPH, received the American Association for Cancer Research’s Minorities in Cancer Research Jane Cooke Wright Lectureship at the AACR Annual Meeting 2024.

PHILADELPHIA (April 10, 2024) — Camille Ragin, PhD, MPH, Associate Director for Diversity, Equity, and Inclusion at Fox Chase Cancer Center, received the American Association for Cancer Research’s (AACR) Minorities in Cancer Research Jane Cooke Wright Lectureship. She delivered the lecture at the AACR Annual Meeting 2024 being held in San Diego.

“I am extremely humbled to receive this award. I consider myself blessed to have had mentors who took the time to help me shape my career,” said Ragin. “Being honored with this award is truly special, and I am thrilled to be among its distinguished recipients.”

According to the AACR, Ragin is being recognized for “unprecedented contributions to defining and understanding the genetic, molecular, and environmental factors that contribute to cancer onset and progression in underrepresented patient populations.”

Ragin has also played a major role in consistently providing mentorship to minority researchers. “Paying it forward through team building, mentoring, and capacity building are critical components that I feel will help us to effectively address cancer inequities. I have no doubt that one day we will all get there together.”

Ragin is a Professor in the Cancer Prevention and Control Program Research Program at Fox Chase, which focuses on the integration of basic and applied research in molecular biology, oncology, and the behavioral, social, and population sciences to reduce the burden of cancer.

Her lab researches the molecular epidemiology of cancer in the African diaspora. Ragin has developed multiple projects in this area, such as the African Caribbean Cancer Consortium, a multi-collaborative network that studies cancer risk and outcomes among populations of African ancestry.

She also founded the Cancer Prevention Project of Philadelphia, a research registry of cancer-free participants who help inform population-based molecular epidemiology research studies.

The lectureship is named in honor of Jane Cooke Wright, a pioneer physician in clinical cancer chemotherapy and an AACR member for 59 years. Wright became the highest-ranking black woman at a nationally recognized medical institution in 1967. At the time, there were only a few hundred black, female physicians in the United States.

The lectureship was created in 2006 and is presented each year at the AACR annual meeting to recognize an outstanding scientist who has made significant contributions to the field of cancer research. It additionally recognizes a scientist who has furthered the advancement of minority investigators in cancer research.

Honorees for this lectureship are chosen through nominations by individuals who are currently, or who have previously been affiliated with, an institution that conducts cancer research or related science. The nominees are then considered by an award selection committee composed of an international cohort of cancer research experts appointed by the president of the AACR.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427